Literature DB >> 20124257

Proteolysis sensitizes LDL particles to phospholipolysis by secretory phospholipase A2 group V and secretory sphingomyelinase.

Riia Plihtari1, Eva Hurt-Camejo, Katariina Oörni, Petri T Kovanen.   

Abstract

LDL particles that enter the arterial intima become exposed to proteolytic and lipolytic modifications. The extracellular hydrolases potentially involved in LDL modification include proteolytic enzymes, such as chymase, cathepsin S, and plasmin, and phospholipolytic enzymes, such as secretory phospholipases A2 (sPLA2-IIa and sPLA2-V) and secretory acid sphingomyelinase (sSMase). Here, LDL was first proteolyzed and then subjected to lipolysis, after which the effects of combined proteolysis and lipolysis on LDL fusion and on binding to human aortic proteoglycans (PG) were studied. Chymase and cathepsin S led to more extensive proteolysis and release of peptide fragments from LDL than did plasmin. sPLA2-IIa was not able to hydrolyze unmodified LDL, and even preproteolysis of LDL particles failed to enhance lipolysis by this enzyme. However, preproteolysis with chymase and cathepsin S accelerated lipolysis by sPLA2-V and sSMase, which resulted in enhanced fusion and proteoglycan binding of the preproteolyzed LDL particles. Taken together, the results revealed that proteolysis sensitizes the LDL particles to hydrolysis by sPLA2-V and sSMase. By promoting fusion and binding of LDL to human aortic proteoglycans, the combination of proteolysis and phospholipolysis of LDL particles potentially enhances extracellular accumulation of LDL-derived lipids during atherogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20124257      PMCID: PMC2882729          DOI: 10.1194/jlr.M003103

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  39 in total

Review 1.  Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications.

Authors:  Ira Tabas; Kevin Jon Williams; Jan Borén
Journal:  Circulation       Date:  2007-10-16       Impact factor: 29.690

2.  Differential uptake of proteoglycan-selected subfractions of low density lipoprotein by human macrophages.

Authors:  E Hurt-Camejo; G Camejo; B Rosengren; F Lopez; O Wiklund; G Bondjers
Journal:  J Lipid Res       Date:  1990-08       Impact factor: 5.922

3.  Decrease in pH strongly enhances binding of native, proteolyzed, lipolyzed, and oxidized low density lipoprotein particles to human aortic proteoglycans.

Authors:  Mia Sneck; Petri T Kovanen; Katariina Oörni
Journal:  J Biol Chem       Date:  2005-09-06       Impact factor: 5.157

4.  A microdetermination method for assaying glycosaminoglycans and proteoglycans.

Authors:  P M Bartold; R C Page
Journal:  Anal Biochem       Date:  1985-11-01       Impact factor: 3.365

Review 5.  The interfacial binding surface of phospholipase A2s.

Authors:  Jason M Winget; Ying H Pan; Brian J Bahnson
Journal:  Biochim Biophys Acta       Date:  2006-08-03

6.  Secretory phospholipase A2 group V: lesion distribution, activation by arterial proteoglycans, and induction in aorta by a Western diet.

Authors:  Birgitta Rosengren; Helena Peilot; Mia Umaerus; Ann-Cathrine Jönsson-Rylander; Lillemor Mattsson-Hultén; Carina Hallberg; Philippe Cronet; Mariam Rodriguez-Lee; Eva Hurt-Camejo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-04-06       Impact factor: 8.311

7.  Proteolysis and fusion of low density lipoprotein particles independently strengthen their binding to exocytosed mast cell granules.

Authors:  K Paananen; P T Kovanen
Journal:  J Biol Chem       Date:  1994-01-21       Impact factor: 5.157

8.  Atherogenic properties of LDL particles modified by human group X secreted phospholipase A2 on human endothelial cell function.

Authors:  Sonia-Athina Karabina; Isabelle Brochériou; Gilles Le Naour; Monique Agrapart; Hervé Durand; Michael Gelb; Gérard Lambeau; Ewa Ninio
Journal:  FASEB J       Date:  2006-10-31       Impact factor: 5.191

9.  Sphingomyelinase enhances low density lipoprotein uptake and ability to induce cholesteryl ester accumulation in macrophages.

Authors:  X X Xu; I Tabas
Journal:  J Biol Chem       Date:  1991-12-25       Impact factor: 5.157

10.  Desquamation of human coronary artery endothelium by human mast cell proteases: implications for plaque erosion.

Authors:  Mikko I Mäyränpää; Hanna M Heikkilä; Ken A Lindstedt; Andrew F Walls; Petri T Kovanen
Journal:  Coron Artery Dis       Date:  2006-11       Impact factor: 1.439

View more
  8 in total

1.  Effects of phospholipase A(2) and its products on structural stability of human LDL: relevance to formation of LDL-derived lipid droplets.

Authors:  Shobini Jayaraman; Donald L Gantz; Olga Gursky
Journal:  J Lipid Res       Date:  2011-01-10       Impact factor: 5.922

2.  Aggregated electronegative low density lipoprotein in human plasma shows a high tendency toward phospholipolysis and particle fusion.

Authors:  Cristina Bancells; Sandra Villegas; Francisco J Blanco; Sonia Benítez; Isaac Gállego; Lorea Beloki; Montserrat Pérez-Cuellar; Jordi Ordóñez-Llanos; José Luis Sánchez-Quesada
Journal:  J Biol Chem       Date:  2010-07-29       Impact factor: 5.157

3.  Kinetic analysis of thermal stability of human low density lipoproteins: a model for LDL fusion in atherogenesis.

Authors:  Mengxiao Lu; Donald L Gantz; Haya Herscovitz; Olga Gursky
Journal:  J Lipid Res       Date:  2012-07-31       Impact factor: 5.922

4.  Conformational changes of apoB-100 in SMase-modified LDL mediate formation of large aggregates at acidic pH.

Authors:  Mia Sneck; Su Duy Nguyen; Tero Pihlajamaa; Gebrenegus Yohannes; Marja-Liisa Riekkola; Ross Milne; Petri T Kovanen; Katariina Oörni
Journal:  J Lipid Res       Date:  2012-06-20       Impact factor: 5.922

Review 5.  Acidification of the intimal fluid: the perfect storm for atherogenesis.

Authors:  Katariina Öörni; Kristiina Rajamäki; Su Duy Nguyen; Katariina Lähdesmäki; Riia Plihtari; Miriam Lee-Rueckert; Petri T Kovanen
Journal:  J Lipid Res       Date:  2014-11-25       Impact factor: 5.922

6.  Susceptibility of low-density lipoprotein particles to aggregate depends on particle lipidome, is modifiable, and associates with future cardiovascular deaths.

Authors:  Maija Ruuth; Su Duy Nguyen; Terhi Vihervaara; Mika Hilvo; Teemu D Laajala; Pradeep Kumar Kondadi; Anton Gisterå; Hanna Lähteenmäki; Tiia Kittilä; Jenni Huusko; Matti Uusitupa; Ursula Schwab; Markku J Savolainen; Juha Sinisalo; Marja-Liisa Lokki; Markku S Nieminen; Antti Jula; Markus Perola; Seppo Ylä-Herttula; Lawrence Rudel; Anssi Öörni; Marc Baumann; Amos Baruch; Reijo Laaksonen; Daniel F J Ketelhuth; Tero Aittokallio; Matti Jauhiainen; Reijo Käkelä; Jan Borén; Kevin Jon Williams; Petri T Kovanen; Katariina Öörni
Journal:  Eur Heart J       Date:  2018-07-14       Impact factor: 29.983

Review 7.  Modified Lipoproteins Induce Arterial Wall Inflammation During Atherogenesis.

Authors:  Martina B Lorey; Katariina Öörni; Petri T Kovanen
Journal:  Front Cardiovasc Med       Date:  2022-03-03

8.  Modified lipoprotein-derived lipid particles accumulate in human stenotic aortic valves.

Authors:  Satu Lehti; Reijo Käkelä; Sohvi Hörkkö; Outi Kummu; Satu Helske-Suihko; Markku Kupari; Kalervo Werkkala; Petri T Kovanen; Katariina Oörni
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.